Saturday, February 10, 2018 7:59:14 PM
Compassionate/Expanded Use. some of these might be of interest.
Expanded Access to Investigational Medical Devices/drugs
"There may be circumstances under which a health care provider may wish to use an unapproved device to save the life of a patient or to help a patient suffering from a serious disease or condition for which there no other alternative therapy exists. Learn more about IDEs and the expanded access requirements for medical devices.
back to top
"In some cases, patients may have to pay for using the investigational drug and/or for medical care associated with the use of the investigational drug. In others, pharmaceutical companies may elect not to charge.
https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/default.htm#Expanded_Access_to_Investigational_Medical_Devices
https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/default.htm
*****************
We provide information and access to treatment options within Clinical Trials & Early Access Programs
"myTomorrows"
https://mytomorrows.com/en/?utm_campaign=AW_EMEAU_ENG_Brand_Desktop_Hygiene_22.01.18_BR01WWENGV2_BMM&utm_source=google&utm_medium=cpc&utm_term=%2Bcompassionate%20%2Buse&utm_content=EMEAU_ENG_HY_TextAd5V4&utm_id=787118616&gclid=EAIaIQobChMIrNn7icic2QIViz2BCh2mVAPqEAAYASAAEgLib_D_BwE
***************
FDA Simplifies Compassionate Use Application and Drug Costs
https://www.medscape.com/viewarticle/864310
******************
Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs
http://www.nejm.org/doi/full/10.1056/NEJMhle1409465
*************************
Working Group on Compassionate Use and Pre-Approval Access
https://med.nyu.edu/pophealth/divisions/medical-ethics/compassionate-use
****************************
Compassionate Drug Use - American Cancer Society (speaking CAR-T cancer therapy)
" Some drug companies will supply the drug for free, but others charge patients. Most insurance companies will not pay for investigational drugs. There may also be ...
https://www.cancer.org/treatment/treatments-and-side-effects/clinical-trials/compassionate-drug-use.html
**************************************
An overview of Compassionate Use Programs in the European Union member states
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116859/
Expanded Access to Investigational Medical Devices/drugs
"There may be circumstances under which a health care provider may wish to use an unapproved device to save the life of a patient or to help a patient suffering from a serious disease or condition for which there no other alternative therapy exists. Learn more about IDEs and the expanded access requirements for medical devices.
back to top
"In some cases, patients may have to pay for using the investigational drug and/or for medical care associated with the use of the investigational drug. In others, pharmaceutical companies may elect not to charge.
https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/default.htm#Expanded_Access_to_Investigational_Medical_Devices
https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/default.htm
*****************
We provide information and access to treatment options within Clinical Trials & Early Access Programs
"myTomorrows"
https://mytomorrows.com/en/?utm_campaign=AW_EMEAU_ENG_Brand_Desktop_Hygiene_22.01.18_BR01WWENGV2_BMM&utm_source=google&utm_medium=cpc&utm_term=%2Bcompassionate%20%2Buse&utm_content=EMEAU_ENG_HY_TextAd5V4&utm_id=787118616&gclid=EAIaIQobChMIrNn7icic2QIViz2BCh2mVAPqEAAYASAAEgLib_D_BwE
***************
FDA Simplifies Compassionate Use Application and Drug Costs
https://www.medscape.com/viewarticle/864310
******************
Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs
http://www.nejm.org/doi/full/10.1056/NEJMhle1409465
*************************
Working Group on Compassionate Use and Pre-Approval Access
https://med.nyu.edu/pophealth/divisions/medical-ethics/compassionate-use
****************************
Compassionate Drug Use - American Cancer Society (speaking CAR-T cancer therapy)
" Some drug companies will supply the drug for free, but others charge patients. Most insurance companies will not pay for investigational drugs. There may also be ...
https://www.cancer.org/treatment/treatments-and-side-effects/clinical-trials/compassionate-drug-use.html
**************************************
An overview of Compassionate Use Programs in the European Union member states
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116859/
Recent CTSO News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/15/2026 09:18:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 11:00:20 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 11:04:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:27:51 PM
- CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/25/2026 08:05:00 PM
- CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 • PR Newswire (US) • 03/19/2026 01:44:00 PM
- CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/05/2026 12:00:00 PM
- CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update • PR Newswire (US) • 01/12/2026 12:00:00 PM
- CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 • PR Newswire (US) • 12/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 02:09:45 AM
- Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London • PR Newswire (US) • 11/17/2025 10:42:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:34:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:32:19 PM
- CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update • PR Newswire (US) • 11/13/2025 09:05:00 PM
- CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London • PR Newswire (US) • 11/11/2025 12:00:00 PM
- CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 10/30/2025 11:00:00 AM
- In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer • PR Newswire (US) • 10/28/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 08:20:54 PM
- CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen • PR Newswire (US) • 09/29/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2025 08:35:38 PM
- CytoSorbents Provides DrugSorb-ATR Regulatory Update • PR Newswire (US) • 09/16/2025 11:00:00 AM
- CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day • PR Newswire (US) • 09/08/2025 11:00:00 AM
- CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference • PR Newswire (US) • 09/05/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2025 08:05:59 PM
- CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR • PR Newswire (US) • 08/20/2025 11:00:00 AM
